Kindstar Globalgene Technology, Inc. (HKG:9960)
1.090
+0.040 (3.81%)
At close: Mar 27, 2026
HKG:9960 Revenue
In the year 2025, Kindstar Globalgene Technology had annual revenue of 933.57M CNY with 0.65% growth. Kindstar Globalgene Technology had revenue of 456.92M in the half year ending June 30, 2025, a decrease of -7.27%.
Revenue
933.57M CNY
Revenue Growth
+0.65%
P/S Ratio
1.05
Revenue / Employee
295.25K CNY
Employees
3,162
Market Cap
1.09B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 933.57M | 6.00M | 0.65% |
| Dec 31, 2024 | 927.57M | -39.69M | -4.10% |
| Dec 31, 2023 | 967.26M | -419.33M | -30.24% |
| Dec 31, 2022 | 1.39B | 455.92M | 48.99% |
| Dec 31, 2021 | 930.67M | 39.28M | 4.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi XDC Cayman | 6.61B |
| Adicon Holdings | 2.94B |
| Yunkang Group | 706.95M |
| Biosino Bio-Technology and Science Incorporation | 246.61M |
| Guanze Medical Information Industry (Holding) | 161.70M |
| Mega Genomics | 151.45M |
| King International Investment | 77.50M |
| China Biotech Services Holdings | 76.93M |